Imaging in Sarcoidosis

ABSTRACT

Sarcoidosis is a multisystemic granulomatous disease of unknown etiology that may involve virtually any organ. Pulmonary involvement predominates, but sarcoidosis can involve multiple organs, with or without concomitant lung involvement. Aberrations on chest radiographs are present in more than 90% of patients with sarcoidosis. Bilateral hilar lymphadenopathy, with or without lung parenchymal infiltrates, is typical but a wide range of chest radiographic patterns may be observed. This article discusses the characteristic chest radiographic features of sarcoidosis and the prognostic value of the radiographic staging classification as espoused by Scadding more than 4 decades ago. Thin-section high-resolution computed tomographic (HRCT) scans more clearly elucidate the intrathoracic lesions observed in sarcoidosis and may discriminate active inflammation from end-stage fibrosis. Although HRCT is not necessary to manage all cases of sarcoidosis, HRCT may be invaluable in selected patients with stage II or III sarcoidosis to discriminate alveolitis (which may be amenable to therapy) from fibrosis. Additionally, radionuclide techniques may have a role in extrapulmonary sarcoidosis (particularly when central nervous system or cardiac involvement is suspected). We review the salient features and role of magnetic resonance imaging and diverse radionuclide techniques to diagnose or follow selected cases of extrapulmonary sarcoidosis.

Sarcoidosis - chest radiographs - computed tomographic (CT) scans - magnetic resonance imaging (MRI) - radionuclide scans

REFERENCES

• 1 Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.  Am J Respir Crit Care Med. 1999;  160 736-755
• 2 Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis.  Allergy. 2005;  60 565-582
• 3 Lynch J P, Kazerooni E A, Gay S E. Pulmonary sarcoidosis.  Clin Chest Med. 1997;  18 755-785
• 4 Mayock R L, Bertrand P, Morrison C E, Scott J H. Manifestations of sarcoidosis. Analysis of 145 patients, with a review of nine series selected from the literature.  Am J Med. 1963;  35 67-89
• 5 Johns C J, Michele T M. The clinical management of sarcoidosis: a 50-year experience at the John Hopkins Hospital.  Medicine (Baltimore). 1999;  78 65-111
• 6 Scadding J G. Prognosis of intrathoracic sarcoidosis in England.  Br Med J. 1961;  2 1165-1172
• 7 Mana J, Gomez-Vaquero C, Montero A et al.. Lofgren's syndrome revisited: a study of 186 patients.  Am J Med. 1999;  107 240-245
• 8 Winterbauer R H, Belic N, Moores K D. Clinical interpretation of bilateral hilar adenopathy.  Ann Intern Med. 1973;  78 65-71
• 9 Bein M E, Putman C E, McLoud T C, Mink J H. A reevaluation of intrathoracic lymphadenopathy in sarcoidosis.  AJR Am J Roentgenol. 1978;  131 409-413
• 10 Littner M R, Schachter E N, Putman C E et al.. The clinical assessment of roentgenographically atypical pulmonary sarcoidosis.  Am J Med. 1977;  62 361-368
• 11 Rockoff S D, Rohatgi P K. Unusual manifestations of thoracic sarcoidosis.  AJR Am J Roentgenol. 1985;  144 513-528
• 12 Conant E F, Glickstein M F, Mahar P et al.. Pulmonary sarcoidosis in the older patient: conventional radiographic features.  Radiology. 1988;  169 315-319
• 13 Sharma O P, Hewlett R, Gordonson J. Nodular sarcoidosis: an unusual radiographic appearance.  Chest. 1973;  64 189-192
• 14 Onal E, Lopata M, Lourenco R V. Nodular pulmonary sarcoidosis: clinical, roentgenographic, and physiologic course in five patients.  Chest. 1977;  72 296-300
• 15 Romer F K. Sarcoidosis with large nodular lesions simulating pulmonary metastases: an analysis of 126 cases of intrathoracic sarcoidosis.  Scand J Respir Dis. 1977;  58 11-16
• 16 Battesti J P, Saumon G, Valeyre D et al.. Pulmonary sarcoidosis with an alveolar radiographic pattern.  Thorax. 1982;  37 448-452
• 17 Tazi A, Desfemmes-Baleyte T, Soler P et al.. Pulmonary sarcoidosis with a diffuse ground-glass pattern on the chest radiograph.  Thorax. 1994;  49 793-797
• 18 Rohatgi P K, Schwab L E. Primary acute pulmonary cavitation in sarcoidosis.  AJR Am J Roentgenol. 1980;  134 1199-1203
• 19 Sharma O P, Gordonson J. Pleural effusion in sarcoidosis: a report of six cases.  Thorax. 1975;  30 95-101
• 20 Soskel N, Sharma O P. Pleural involvement in sarcoidosis: case presentation and detailed review of the literature.  Semin Respir Med. 1992;  13 492-514
• 21 Mendelson D S, Norton K, Cohen B A et al.. Bronchial compression: an unusual manifestation of sarcoidosis.  J Comput Assist Tomogr. 1983;  7 892-894
• 22 Munt P W. Middle lobe atelectasis in sarcoidosis.  Am Rev Respir Dis. 1973;  108 357-360
• 23 Siltzbach L E, James D G, Neville E et al.. Course and prognosis of sarcoidosis around the world.  Am J Med. 1974;  57 847-852
• 24 Romer F K. Presentation of sarcoidosis and outcome of pulmonary changes.  Dan Med Bull. 1982;  29 27-32
• 25 Hillerdal G, Nou E, Osterman K et al.. Sarcoidosis: epidemiology and prognosis: a 15-year European study.  Am Rev Respir Dis. 1984;  130 29-32
• 26 Gibson G J, Prescott R J, Muers M F et al.. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment.  Thorax. 1996;  51 238-247
• 27 Pietinalho A, Tukiainen P, Haahtela T et al.. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group.  Chest. 1999;  116 424-431
• 28 Pietinalho A, Tukiainen P, Haahtela T et al.. Early treatment of stage II sarcoidosis improves 5-year pulmonary function.  Chest. 2002;  121 24-31
• 29 Hansell D M. High-resolution CT of diffuse lung disease: value and limitations.  Radiol Clin North Am. 2001;  39 1091-1113
• 30 Beigelman-Aubry C, Hill C, Guibal A, Savatovsky J, Grenier P A. Multi-detector row CT and postprocessing techniques in the assessment of diffuse lung disease.  Radiographics. 2005;  25 1639-1652
• 31 Bergin C J, Coblentz C L, Chiles C et al.. Chronic lung diseases: specific diagnosis by using CT.  AJR Am J Roentgenol. 1989;  152 1183-1188
• 32 Mathieson J R, Mayo J R, Staples C A et al.. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography.  Radiology. 1989;  171 111-116
• 33 Padley S P, Hansell D M, Flower C D et al.. Comparative accuracy of high-resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease.  Clin Radiol. 1991;  44 222-226
• 34 Grenier P, Valeyre D, Cluzel P et al.. Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT.  Radiology. 1991;  179 123-132
• 35 Grenier P, Chevret S, Beigelman C et al.. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis.  Radiology. 1994;  191 383-390
• 36 Nishimura K, Izumi T, Kitaichi M et al.. The diagnostic accuracy of high-resolution computed tomography in diffuse infiltrative lung diseases.  Chest. 1993;  104 1149-1155
• 37 Mana J, Teirstein A S, Mendelson D S et al.. Excessive thoracic computed tomographic scanning in sarcoidosis.  Thorax. 1995;  50 1264-1266
• 38 Lynch D A, Webb W R, Gamsu G et al.. Computed tomography in pulmonary sarcoidosis.  J Comput Assist Tomogr. 1989;  13 405-410
• 39 Brauner M W, Lenoir S, Grenier P et al.. Pulmonary sarcoidosis: CT assessment of lesion reversibility.  Radiology. 1992;  182 349-354
• 40 Remy-Jardin M, Giraud F, Remy J et al.. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment.  Radiology. 1994;  191 675-680
• 41 Murdoch J, Müller N L. Pulmonary sarcoidosis: changes on follow-up CT examination.  AJR Am J Roentgenol. 1992;  159 473-477
• 42 Leung A N, Brauner M W, Caillat-Vigneron N et al.. Sarcoidosis activity: correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay.  J Comput Assist Tomogr. 1998;  22 229-234
• 43 Oberstein A, von Zitzewitz H, Schweden F, Muller-Quernheim J. Noninvasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography.  Sarcoidosis Vasc Diffuse Lung Dis. 1997;  14 65-72
• 44 Abehsera M, Valeyre D, Grenier P et al.. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function.  AJR Am J Roentgenol. 2000;  174 1751-1757
• 45 Bergin C J, Bell D Y, Coblentz C L et al.. Sarcoidosis: correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests.  Radiology. 1989;  171 619-624
• 46 Müller N L, Mawson J B, Mathieson J R et al.. Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings.  Radiology. 1989;  171 613-618
• 47 Brauner M W, Grenier P, Mompoint D et al.. Pulmonary sarcoidosis: evaluation with high-resolution CT.  Radiology. 1989;  172 467-471
• 48 Hansell D M, Milne D G, Wilsher M L et al.. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT.  Radiology. 1998;  209 697-704
• 49 Davies C W, Tasker A D, Padley S P et al.. Air trapping in sarcoidosis on computed tomography: correlation with lung function.  Clin Radiol. 2000;  55 217-221
• 50 Magkanas E, Voloudaki A, Bouros D et al.. Pulmonary sarcoidosis: correlation of expiratory high-resolution CT findings with inspiratory patterns and pulmonary function tests.  Acta Radiol. 2001;  42 494-501
• 51 Drent M, De Vries J, Lenters M et al.. Sarcoidosis: assessment of disease severity using HRCT.  Eur Radiol. 2003;  13 2462-2471
• 52 Terasaki H, Fujimoto K, Muller N L et al.. Pulmonary sarcoidosis: comparison of findings of inspiratory and expiratory high-resolution CT and pulmonary function tests between smokers and nonsmokers.  AJR Am J Roentgenol. 2005;  185 333-338
• 53 Akira M, Kozuka T, Inoue Y, Sakatani M. Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis.  Chest. 2005;  127 185-191
• 54 Hamper U M, Fishman E K, Khouri N F et al.. Typical and atypical CT manifestations of pulmonary sarcoidosis.  J Comput Assist Tomogr. 1986;  10 928-936
• 55 Müller N L, Kullnig P, Miller R R. The CT findings of pulmonary sarcoidosis: analysis of 25 patients.  AJR Am J Roentgenol. 1989;  152 1179-1182
• 56 Lenique F, Brauner M W, Grenier P et al.. CT assessment of bronchi in sarcoidosis: endoscopic and pathologic correlations.  Radiology. 1995;  194 419-423
• 57 Sider L, Horton Jr E S. Hilar and mediastinal adenopathy in sarcoidosis as detected by computed tomography.  J Thorac Imaging. 1990;  5 77-80
• 58 Gawne-Cain M L, Hansell D M. The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis: a CT study.  Clin Radiol. 1996;  51 263-267
• 59 Patil S N, Levin D L. Distribution of thoracic lymphadenopathy in sarcoidosis using computed tomography.  J Thorac Imaging. 1999;  14 114-117
• 60 Niimi H, Kang E Y, Kwong J S et al.. CT of chronic infiltrative lung disease: prevalence of mediastinal lymphadenopathy.  J Comput Assist Tomogr. 1996;  20 305-308
• 61 Wells A. High resolution computed tomography in sarcoidosis: a clinical perspective.  Sarcoidosis Vasc Diffuse Lung Dis. 1998;  15 140-146
• 62 Lynch III J P. Computed tomographic scanning in sarcoidosis.  Semin Respir Crit Care Med. 2003;  24 393-418
• 63 Nishimura K, Itoh H, Kitaichi M et al.. Pulmonary sarcoidosis: correlation of CT and histopathologic findings.  Radiology. 1993;  189 105-109
• 64 Honda O, Johkoh T, Ichikado K et al.. Comparison of high resolution CT findings of sarcoidosis, lymphoma, and lymphangitic carcinoma: is there any difference of involved interstitium?.  J Comput Assist Tomogr. 1999;  23 374-379
• 65 Nakatsu M, Hatabu H, Morikawa K et al.. Large coalescent parenchymal nodules in pulmonary sarcoidosis: “sarcoid galaxy” sign.  AJR Am J Roentgenol. 2002;  178 1389-1393
• 66 Remy-Jardin M, Giraud F, Remy J et al.. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation.  Radiology. 1993;  189 693-698
• 67 Gleeson F V, Traill Z C, Hansell D M. Evidence of expiratory CT scans of small-airway obstruction in sarcoidosis.  AJR Am J Roentgenol. 1996;  166 1052-1054
• 68 Bartz R R, Stern E J. Airways obstruction in patients with sarcoidosis: expiratory CT scan findings.  J Thorac Imaging. 2000;  15 285-289
• 69 Fazzi P, Sbragia P, Solfanelli S et al.. Functional significance of the decreased attenuation sign on expiratory CT in pulmonary sarcoidosis: report of four cases.  Chest. 2001;  119 1270-1274
• 70 Nishino M, Kuroki M, Roberts D H et al.. Bronchomalacia in sarcoidosis: evaluation on volumetric expiratory high-resolution CT of the lung.  Acad Radiol. 2005;  12 596-601
• 71 Dalal P U, Hansell D M. High-resolution computed tomography of the lungs: the borderlands of normality.  Eur Radiol. 2006;  16 771-780
• 72 Aye M, Campbell A P, Greenstone M A. An unusual case of lobar collapse.  Chest. 2002;  122 1465-1466
• 73 Nunes H, Humbert M, Capron F et al.. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis.  Thorax. 2006;  61 68-74
• 74 Narayan D, Brown L, Thayer J O. Surgical management of superior vena caval syndrome in sarcoidosis.  Ann Thorac Surg. 1998;  66 946-948
• 75 Cappell M S. Endoscopic, radiographic, and manometric findings in dysphagia associated with sarcoid due to extrinsic esophageal compression from subcarinal lymphadenopathy.  Am J Gastroenterol. 1995;  90 489-492
• 76 Tobias J K, Santiago S M, Williams A J. Sarcoidosis as a cause of left recurrent laryngeal nerve palsy.  Arch Otolaryngol Head Neck Surg. 1990;  116 971-972
• 77 Jarman P R, Whyte M K, Sabroe I, Hughes J M. Sarcoidosis presenting with chylothorax.  Thorax. 1995;  50 1324-1325
• 78 Johkoh T, Ikezoe J, Takeuchi N et al.. CT findings in “pseudoalveolar” sarcoidosis.  J Comput Assist Tomogr. 1992;  16 904-907
• 79 Liebow A A, The J. Burns Amberson lecture: pulmonary angiitis and granulomatosis.  Am Rev Respir Dis. 1973;  108 1-18
• 80 Quaden C, Tillie-Leblond I, Delobbe A et al.. Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiological evaluations.  Eur Respir J. 2005;  26 778-785
• 81 Mackie B, Humphrey D A, Flannery M T. Atypical sarcoidosis: a case report and literature review.  Am J Med Sci. 2006;  331 277-279
• 82 Ozseker Z F, Yilmaz A, Bayramgurler B et al.. Cavitary sarcoidosis: analysis of two cases.  Respirology. 2002;  7 289-291
• 83 Froudarakis M E, Bouros D, Voloudaki A et al.. Pneumothorax as a first manifestation of sarcoidosis.  Chest. 1997;  112 278-280
• 84 Ichikawa Y, Fujimoto K, Shiraishi T et al.. Primary cavitary sarcoidosis: high-resolution CT findings.  AJR Am J Roentgenol. 1994;  163 745
• 85 Flora G, Dostanic D, Jakovic R et al.. Pneumothorax in sarcoidosis.  Sarcoidosis. 1991;  8 75-79
• 86 Padley S P, Padhani A R, Nicholson A et al.. Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT.  Clin Radiol. 1996;  51 807-810
• 87 Gruden J F, Webb W R, Naidich D P, McGuinness G. Multinodular disease: anatomic localization at thin-section CT-multireader evaluation of a simple algorithm.  Radiology. 1999;  210 711-720
• 88 Tsiodras S, Eiger G, Guttentag A, Lippmann M. Sarcoidosis presenting as unilateral alveolar consolidation.  Am J Med Sci. 1997;  314 346-347
• 89 Gotway M B, Tchao N K, Leung J WT et al.. Sarcoidosis presenting as an enlarging solitary pulmonary nodule.  J Thorac Imaging. 2001;  16 117-122
• 90 Judson M A, Uflacker R. Treatment of a solitary pulmonary sarcoidosis mass by CT-guided direct intralesional injection of corticosteroid.  Chest. 2001;  120 316-317
• 91 Ito A, Fujino M, Isada A et al.. Retrograde radiographic development in pulmonary sarcoidosis.  Intern Med. 2006;  45 819-822
• 92 Marten K, Rummeny E J, Engelke C. The CT halo: a new sign in active pulmonary sarcoidosis.  Br J Radiol. 2004;  77 1042-1045
• 93 Marlow T J, Krapiva P I, Schabel S I et al.. The “fairy ring”: a new radiographic finding in sarcoidosis.  Chest. 1999;  115 275-276
• 94 Weinstein D S. Pulmonary sarcoidosis: calcified micronodular pattern simulating pulmonary alveolar microlithiasis.  J Thorac Imaging. 1999;  14 218-220
• 95 Szwarcberg J B, Glajchen N, Teirstein A S. Pleural involvement in chronic sarcoidosis detected by thoracic CT scanning.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 58-62
• 96 Kaiser P K, Lowder C Y, Sullivan P et al.. Chest computerized tomography in the evaluation of uveitis in elderly women.  Am J Ophthalmol. 2002;  133 499-505
• 97 Hennebicque A S, Nunes H, Brillet P Y et al.. CT findings in severe thoracic sarcoidosis.  Eur Radiol. 2005;  15 23-30
• 98 Wollschlager C, Khan F. Aspergillomas complicating sarcoidosis: a prospective study in 100 patients.  Chest. 1984;  86 585-588
• 99 Franquet T, Muller N L, Gimenez A et al.. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings.  Radiographics. 2001;  21 825-837
• 100 Shorr A F, Helman D L, Davies D B, Nathan S D. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics.  Eur Respir J. 2005;  25 783-788
• 101 Battesti J-P, Georges R, Basset F, Saumon G. Chronic cor pulmonale in pulmonary sarcoidosis.  Thorax. 1978;  33 76-84
• 102 Damuth T E, Bower J S, Cho K, Dantzker D R. Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis.  Chest. 1980;  78 888-891
• 103 Smith L J, Lawrence J B, Katzenstein A L. Vascular sarcoidosis: a rare cause of pulmonary hypertension.  Am J Med Sci. 1983;  285 38-44
• 104 Hoffstein V, Ranganathan N, Mullen J BM. Sarcoidosis simulating pulmonary veno-occlusive disease.  Am Rev Respir Dis. 1986;  134 809-811
• 105 Barst R J, Ratner S J. Sarcoidosis and reactive pulmonary hypertension.  Arch Intern Med. 1985;  145 2112-2114
• 106 Craig D A, Colletti P M, Ratto D et al.. MRI findings in pulmonary sarcoidosis.  Magn Reson Imaging. 1988;  6 567-573
• 107 Mendelson D S, Gray C E, Teirstein A S. Magnetic resonance findings in sarcoidosis of the thorax.  Magn Reson Imaging. 1992;  10 523-529
• 108 McFadden R G, Carr T J, Wood T E. Proton magnetic resonance imaging to stage activity of interstitial lung disease.  Chest. 1987;  92 31-39
• 109 Muller N L, Mayo J R, Zwirewich C V. Value of MR imaging in the evaluation of chronic infiltrative lung diseases: comparison with CT.  AJR Am J Roentgenol. 1992;  158 1205-1209
• 110 Primack S L, Mayo J R, Hartman T E et al.. MRI of infiltrative lung disease: comparison with pathologic findings.  J Comput Assist Tomogr. 1994;  18 233-238
• 111 Gaeta M, Blandino A, Scribano E et al.. Chronic infiltrative lung diseases: value of gadolinium-enhanced MRI in the evaluation of disease activity-early report.  Chest. 2000;  117 1173-1178
• 112 Mana J. Magnetic resonance imaging and nuclear imaging in sarcoidosis.  Curr Opin Pulm Med. 2002;  8 457-463
• 113 Jacobs M P, Baughman R P, Hughes J, Fernandez-Ulloa M. Radioaerosol lung clearance in patients with active pulmonary sarcoidosis.  Am Rev Respir Dis. 1985;  131 687-689
• 114 Dusser D J, Collignon M A, Stanislas-Leguern G et al.. Respiratory clearance of 99mTc-DTPA and pulmonary involvement in sarcoidosis.  Am Rev Respir Dis. 1986;  134 493-497
• 115 Thunberg S, Larsson K, Eklund A, Blaschke E. 99mTc-DTPA clearance measured by a dual head gamma camera in healthy subjects and patients with sarcoidosis: studies of reproducibility and relation to bronchoalveolar lavage findings.  Eur J Nucl Med. 1989;  15 71-77
• 116 Chinet T, Dusser D, Labrune S et al.. Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA.  Am Rev Respir Dis. 1990;  141 445-449
• 117 Bradvik I, Wollmer P, Evander E et al.. Different kinetics of lung clearance of technetium-99m labelled diethylene triamine penta-acetic acid in patients with sarcoidosis and smokers.  Eur J Nucl Med. 1994;  21 1218-1222
• 118 Bradvik I, Wollmer P, Evander E et al.. One year follow-up of lung clearance of 99mTc-diethylene triamine penta-acetic acid and disease activity in sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2000;  17 281-287
• 119 Bradvik I, Wollmer P, Evander E et al.. Kinetics of lung clearance of 99mTc-DTPA in smoking patients with sarcoidosis compared to healthy smokers.  Respir Med. 2002;  96 317-321
• 120 Hoitsma E, Faber C G, Drent M, Sharma O P. Neurosarcoidosis: a clinical dilemma.  Lancet Neurol. 2004;  3 397-407
• 121 Smith J K, Matheus M G, Castillo M. Imaging manifestations of neurosarcoidosis.  AJR Am J Roentgenol. 2004;  182 289-295
• 122 Christoforidis G A, Spickler E M, Recio M V, Mehta B M. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment.  AJNR Am J Neuroradiol. 1999;  20 655-669
• 123 Hayes W S, Sherman J L, Stern B J et al.. MR and CT evaluation of intracranial sarcoidosis.  AJR Am J Roentgenol. 1987;  149 1043-1049
• 124 Sherman J L, Stern B J. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images.  AJR Am J Roentgenol. 1990;  155 1293-1301
• 125 Seltzer S, Mark A S, Atlas S W. CNS sarcoidosis: evaluation with contrast-enhanced MR imaging.  AJNR Am J Neuroradiol. 1991;  12 1227-1233
• 126 Dumas J L, Valeyre D, Chapelon-Abric C et al.. Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy.  Radiology. 2000;  214 411-420
• 127 Lexa F J, Grossman R I. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy.  AJNR Am J Neuroradiol. 1994;  15 973-982
• 128 Junger S S, Stern B J, Levine S R et al.. Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics.  Neurology. 1993;  43 333-337
• 129 Pickuth D, Heywang-Kobrunner S H. Neurosarcoidosis: evaluation with MRI.  J Neuroradiol. 2000;  27 185-188
• 130 Koike H, Misu K, Yasui K et al.. Differential response to corticosteroid therapy of MRI findings and clinical manifestations in spinal cord sarcoidosis.  J Neurol. 2000;  247 544-549
• 131 Doughan A R, Williams B R. Cardiac sarcoidosis.  Heart. 2006;  92 282-288
• 132 Nakazawa A, Ikeda K, Ito Y et al.. Usefulness of dual 67Ga and 99mTc-sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis.  Chest. 2004;  126 1372-1376
• 133 Barneveld P C, van Leeuwen C, van Isselt J W. Scintigraphic demonstration of myocardial sarcoidosis: the added value of single-photon emission computed tomography.  J Nucl Cardiol. 1997;  4 256-257
• 134 Vignaux O. Cardiac sarcoidosis: spectrum of MRI features.  AJR Am J Roentgenol. 2005;  184 249-254
• 135 Shimada T, Shimada K, Sakane T et al.. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.  Am J Med. 2001;  110 520-527
• 136 Vignaux O, Dhote R, Duboc D et al.. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study.  J Comput Assist Tomogr. 2002;  26 762-767
• 137 Vignaux O, Dhote R, Duboc D et al.. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study.  Chest. 2002;  122 1895-1901
• 138 Skold C M, Larsen F F, Rasmussen E et al.. Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography.  J Intern Med. 2002;  252 465-471
• 139 Smedema J P, Snoep G, van Kroonenburgh M P et al.. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.  J Am Coll Cardiol. 2005;  45 1683-1690
• 140 Tadamura E, Yamamuro M, Kubo S et al.. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging.  AJR Am J Roentgenol. 2005;  185 110-115
• 141 Smedema J P, Snoep G, van Kroonenburgh M P et al.. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis.  Chest. 2005;  128 1629-1637
• 142 Yamagishi H, Shirai N, Takagi M et al.. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.  J Nucl Med. 2003;  44 1030-1036
• 143 Okumura W, Iwasaki T, Toyama T et al.. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.  J Nucl Med. 2004;  45 1989-1998
• 144 Ishimaru S, Tsujino I, Takei T et al.. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.  Eur Heart J. 2005;  26 1538-1543
• 145 Kaminaga T, Takeshita T, Yamauchi T et al.. The role of iodine-123-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis.  Int J Cardiol. 2004;  94 99-103
• 146 Hyodo E, Hozumi T, Takemoto Y et al.. Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation.  Heart. 2004;  90 1275-1280
• 147 Kanao S, Tadamura E, Yamamuro M et al.. Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging.  J Comput Assist Tomogr. 2005;  29 745-748
• 148 Sulavik S B, Spencer R P, Weed D A et al.. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis.  J Nucl Med. 1990;  31 1909-1914
• 149 Israel H L, Albertine K H, Park C H, Patrick H. Whole-body gallium 67 scans: role in diagnosis of sarcoidosis.  Am Rev Respir Dis. 1991;  144 1182-1186
• 150 Sulavik S B, Spencer R P, Palestro C J et al.. Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the noninvasive diagnosis of sarcoidosis.  Chest. 1993;  103 403-409
• 151 Sulavik S B, Spencer R P, Weed D A et al.. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis.  J Nucl Med. 1990;  31 1909-1914
• 152 Line B R, Hunninghake G W, Keogh B A et al.. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function tests and bronchoalveolar lavage.  Am Rev Respir Dis. 1981;  123 440-446
• 153 Fajman W A, Greenwald L V, Staton G et al.. Assessing the activity of sarcoidosis: quantitative 67Ga-citrate imaging.  AJR Am J Roentgenol. 1984;  142 683-688
• 154 Alberts C, van der Schoot J B, van Daatselaar J J et al.. 67Ga scintigraphy, serum lysozyme and angiotensin-converting enzyme in pulmonary sarcoidosis.  Eur J Respir Dis. 1983;  64 38-46
• 155 Beaumont D, Herry J Y, Sapene M et al.. Gallium-67 in the evaluation of sarcoidosis: correlations with serum angiotensin-converting enzyme and bronchoalveolar lavage.  Thorax. 1982;  37 11-18
• 156 Kohn H, Klech H, Kummer F, Mostbeck A. Assessment of activity in Sarcoidosis: sensitivity and specificity of 67-Gallium scintigraphy, serum ACE levels, chest roentgenography and blood lymphocyte subpopulations.  Chest. 1982;  82 732-738
• 157 Duffy G J, Thirumurthi K, Casey M et al.. Semi-quantitative gallium-67 lung scanning as a measure of the intensity of alveolitis in pulmonary sarcoidosis.  Eur J Nucl Med. 1986;  12 187-191
• 158 Brudin L H, Valind S O, Rhodes C G et al.. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography.  Eur J Nucl Med. 1994;  21 297-305
• 159 Yamada Y, Uchida Y, Tatsumi K et al.. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.  J Nucl Med. 1998;  39 1160-1166